Background. Infections caused by MDRO lead to significant morbidity and mortality. Consequently, several states have mandated reporting of MDRO and C. difficile. Objectives of this study were: 1) to describe policies to screen and isolate for MDRO in U.S. hospitals; and 2) examine the relationship between state mandates for reporting of MDRO and implementation of screening and isolation/contact precaution policies.
Methods. A cross-sectional survey of hospitals enrolled in the National Healthcare Safety Network was conducted in the Fall of 2011. Descriptive statistics were computed. Differences in policies between hospitals located in states with and without MDRO reporting mandates at the time of the survey were examined using chi-square tests.
Results. 1,015 hospitals provided data (30% response rate). The majority (68%) reported targeted screening upon admission for methicillin-resistant Staphylococcus aureus (MRSA); screening for vancomycin-resistant Enterococci (VRE) and C. difficile were infrequently reported, 13% and 5%, respectively. Of hospitals with targeted MRSA screening, populations screened were ICU patients (73%) and transfers from skilled nursing facilities (57%) or other hospitals (43%). Contact precautions (CP) for patients with the following organisms were commonly reported: MRSA (95%), VRE (93%), and C. difficile (86%). While presumptive isolation/CP were common for C. difficile (78%), they were less common for MRSA (39%) and VRE (24%). Few hospitals routinely screened for other organisms, including methicillin-susceptible Staphylococcus aureus (12%), Acinetobacter spp (9%), Klebsiella pneumoniae (8%) and Pseudomonas spp (7%). Hospitals located in states with mandatory reporting of MRSA were more likely to have a policy for targeted MRSA screening ( p < 0.001), and less likely to have a policy for presumptive isolation/CP pending a screen ( p = 0.024).
Conclusion. This study found variation in the adoption of MDRO screening and isolation/contact precautions. Further research is needed to provide additional insight on effective strategies and to examine the impact of mandatory reporting of infections on implementation of policies and infection rates.
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